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Abstract
Group I metabotropic glutamate (mGlu) receptors (i.e. mGlu1 and mGlu5) coupled to phospholipase C have been widely
investigated for their possible role in excitotoxic and post-ischemic neuronal death. Recently, phospholipase C has been shown to
directly stimulate the activity of poly(ADP-ribose) polymerase (PARP), a nuclear enzyme involved in DNA repair that has been
proposed to play a key role in necrotic cell death. In this study, we investigated whether the stimulation of group I mGlu receptors
leads to an increase in PARP activity, as detected by flow cytometry, immunodot blot and immunocytochemistry, both in baby
hamster kidney cells transfected with mGlu1a or mGlu5a receptors and in cultured cortical cells. Our results show that the group I
mGlu receptor agonist DHPG elicited a significant increase in PARP activity that was completely abolished by the administration of
the mGlu1 antagonist 3-MATIDA and partially prevented, in cortical neurons, by the mGlu5 antagonist MPEP. To evaluate
whether this pathway is involved in post-ischemic neuronal death, we used a sublethal model of oxygen-glucose deprivation in mixed
cortical cell cultures. DHPG exacerbated neuronal death, and this effect was significantly prevented by the application of the PARP
inhibitor DPQ. This novel pathway may contribute to the effects of mGlu1 receptors in the mechanisms leading to post-ischemic
neuronal death.
 2005 Elsevier Ltd. All rights reserved.
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Group I metabotropic glutamate (mGlu) receptors,
including mGlu1 and mGlu5 receptors, have been
extensively investigated in the past few years for their
possible involvement in numerous physiological and
pathological states in the brain, including synaptic
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doi:10.1016/j.neuropharm.2005.05.017plasticity, long-term potentiation and depression, apo-
ptosis and neurodegeneration following cerebral ische-
mia (Bordi and Ugolini, 1999; Bruno et al., 2001; Conn
and Pin, 1997; Pellegrini-Giampietro, 2003; Schoepp,
2001). mGlu1 and mGlu5 receptors are thought to
couple through Gq-type G-proteins to phospholipase C
(PLC)-b, which results in intracellular Ca2C mobiliza-
tion via inositol (1,4,5)-trisphosphate (IP3) and ryano-
dine receptors (Fagni et al., 2000; Stefani et al., 1996).
Group I mGlu receptors have also been implicated in
a variety of alternative intracellular transduction
pathways, including adenylyl cyclase (Aramori and
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mitogen-activated protein kinase (Calabresi et al., 2001)
and phosphoinositide 3-kinase (Rong et al., 2003).
Poly(ADP-ribosyl)ation is a post-translational enzy-
matic modification involved in numerous cellular pro-
cesses including DNA repair, genomic integrity and cell
death (Chiarugi, 2002; Herceg and Wang, 2001; Smith,
2001). It is catalyzed by poly(ADP-ribose) polymerases
(PARPs), a growing family of enzymes that convert
NAD into long branched polymers (up to 200 units) of
poly(ADP-ribose) (PAR), which are then attached to
a large number of acceptor nuclear proteins (including
PARP itself). Overactivation of PARP-1, the most studied
member of this family, has been associated with the
pathogenesis of numerous disorders in the CNS, including
excitotoxicity and ischemic injury. A presumed cascade of
glutamate activating NOS, leading to excessive formation
of NO and DNA damage and then to overactivation of
PARP-1, has been proposed to play a ‘‘suicidal role’’ due
to the marked depletion of NAD and ATP tissue stores
and the disruption of oxidative metabolism (Ha and
Snyder, 2000; Herceg and Wang, 2001; Szabo´ and
Dawson, 1998). Accordingly, pharmacological PARP
inhibition or targeted deletion of the PARP-1 gene
provides impressive and unparalleled protection against
neuronal damage in several animal models of excitotox-
icity (Mandir et al., 2000;Moroni et al., 2001; Pieper et al.,
1999).More recent findings also suggest a ‘‘transcriptional
hypothesis’’ for the neurotoxic effects of PARP-1, inwhich
the formation of PAR regulates the gene expression of
neuroactive proteins such as iNOS, IL-1b, COX-2, TNF-
a and APP (Chiarugi, 2002).
Activation of PARP is typically initiated by stressful
stimuli that damageDNA, but recent reports suggest that
it can also be induced by physiological activity, in the
absence of DNA damage (Cohen-Armon et al., 2004). In
particular, it has been demonstrated that PARP can be
rapidly activated by stimulation of PLC and IP3-evoked
Ca2C mobilization (Homburg et al., 2000). Hence, we
decided to investigate whether the stimulation of group I
mGlu receptors could promote the activation of PARP in
baby hamster kidney (BHK) transfected with mGlu1 or
mGlu5 receptors and in cortical cell cultures. Moreover,
we examined whether this mechanism could play a role in
an in vitro model of cerebral ischemia.
2. Methods
2.1. Materials
3-Amino-thiophene-dicarboxylic acid (3-MATIDA)
was synthesized as previously described (Moroni et al.,
2002). (RS )-3,5-dihydroxyphenylglycine (DHPG) and 2-
methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP)
were purchased fromTocris Bioscience (Northpoint, UK),whereas 3,4-dihydro-5-[4-1(1-piperidinyl)buthoxy]-1(2H)-
isoquinolinone (DPQ), the polyclonal rabbit antibody
(LP98-10) and the monoclonal mouse antibody (10H)
directed against PAR were from Alexis Corporation
(Vinci, Italy). Lactate dehydrogenase (LDH) activity was
quantified using the Cytotoxicity Detection Kit (LDH)
fromRocheDiagnostics (Monza,MI, Italy). The anti-glial
fibrillary acidic protein (GFAP) fluoresceine isothiocya-
nate (FITC)-conjugated antibody and the phycoerythrin-
conjugated goat anti-rabbit IgG were purchased from
Molecular Probes Europe (Leiden, The Netherlands).
Tissue culture reagents were obtained from GIBCO-BRL
(Milan, Italy) and ICN Pharmaceuticals (Opera, Milan,
Italy). All other reagents were of analytical grade and
obtained from Merck (Darmstadt, Germany).
2.2. Transfected cell cultures
Baby hamster kidney (BHK) cells stably transfected
with rat mGlu1a or mGlu5a receptors (see Moroni
et al., 2002) were provided by Dr. C. Thomsen (Novo
Nordisk, Denmark) and cultured in Dulbecco’s modi-
fied Eagle’s medium supplemented with 5% dialyzed
fetal bovine serum, 2 mM glutamine, 0.05 mg/ml genta-
micin and 0.1 mg/ml neomycin in a humidified atmo-
sphere (95% air/5% CO2) at 37
C. In addition, the
incubation medium of the transfected cells was supple-
mented with G-418 and methotrexate. Cells were
maintained in a humidified atmosphere (95% air/5%
CO2) at 37
C and subcultured (every second day) using
0.05% trypsin/EDTA.
2.3. Murine cortical cell cultures
Cultures of mixed cortical cells containing both
neuronal and glial elements were prepared as previously
described in detail (Pellegrini-Giampietro et al., 1999a,b)
and used at 14e15 days in vitro (DIV).
2.4. Measurement of PARP activity by flow cytometry
PARP activity was evaluated in BHK transfected cells
and in murine cortical cells by cytofluorimetric measure-
ment of PAR formation according to Affar et al. (1999),
with minor modifications. Following DHPG exposure
(30 min for transfected BHK cells, 60 min for cortical
cells), BHK cell cultures were resuspended and fixed in
4% paraformaldehyde, whereas cortical cell cultures
were detached using 0.05% trypsin for 5 min at 37 C in
PBS, washed with cold PBS and then fixed with 4%
paraformaldehyde at room temperature. Fixed cells were
permeabilized with 0.2% NP-40, washed with PBS,
saturated with PBS-MT (PBS containing 5% non-fat
powdered milk and 0.1% Tween 20) for 1 h and then
incubated overnight at 4 C with anti-PAR (LP98-10,
1:100) and, in the case of mixed cortical cell cultures, with
82 E. Meli et al. / Neuropharmacology 49 (2005) 80e88FITC-conjugated anti-GFAP (1:100) antibodies diluted
in PBS-MT. After several washes with PBS-MT, cells
were incubated with a phycoerythrin-conjugated anti-
rabbit IgG (1:50) for 30 min. The cell suspension
(approximately 10,000 cells per analysis) was analyzed
using a flow cytometer (Coulter XL, Coulter Cytometry,
Hialeah, FL, USA). In the case of mixed cortical cell
suspensions, containing both neurons and astrocytes,
neuron-related events (PAR-positive neurons) were
sorted by subtracting FITC-labeled cells (GFAP-positive
astrocytes) from phycoerythrin-positive cells by means of
appropriate electronic gates.
2.5. Measurement of PARP activity by immunodot blot
In BHK transfected cells, PARP activity was also
evaluated by immunodot blot analysis. Briefly, proteins
were extracted, diluted in NaOH/EDTA and 2 ml of each
sample was loaded onto Hybond NC membranes. After
washing with NaOH and an incubation with PBS-MT,
membranes were exposed overnight to a monoclonal
antibody to PAR (10H, 1:250). An HRP-conjugated
secondary antibody was then added and membrane was
analyzed by a chemiluminescence method (ECL-Plus,
Amersham Biosciences).
2.6. Immunocytochemistry
In mixed cortical cultures, PARP activity was also
evaluated by immunocytochemistry. Mixed cultures
containing both neurons and glia were washed with
cold PBS and then fixed in 100% methanol. Fixed cells
were washed again with cold PBS, saturated with PBS-
MT for 1 h and then exposed for 90 min at 37 C to
a monoclonal antibody to PAR diluted in PBS-MT
(10H, 1:100). After washing with PBS-MT, cells were
incubated 60 min at 37 C with a fluorescent secondary
antibody (Alexa 488, Molecular Probes, 1:50) and then
observed under fluorescence optics.
2.7. Oxygen-glucose deprivation (OGD) in
cortical cell cultures
Cultures of mixed cortical cells were exposed to
oxygen-glucose deprivation (OGD) as previously de-
scribed in detail (Pellegrini-Giampietro et al., 1999a,b).
Briefly, culture medium was replaced by a glucose-free
balanced salt solution saturated with 95% N2/5% CO2
and heated to 37 C. Multiwells were then sealed into an
airtight incubation chamber equipped with inlet and
outlet valves and 95% N2/5% CO2 was blown through
the chamber for 10 min to ensure maximal removal of
oxygen. The chamber was then sealed and placed into
the incubator at 37 C for 60 min. OGD was terminated
by removing the cultures from the chamber, replacing
the exposure solution with oxygenated medium andreturning the multiwells to the incubator under normoxic
conditions. The extent of neuronal death was assessed
24 h later. OGD-induced cell injury was quantitatively
evaluated by measuring the amount of LDH released
from injured cells into culture media 24 h following
exposure to OGD, as previously described (Pellegrini-
Giampietro et al., 1999a,b). The LDH level correspond-
ing to complete neuronal death (with no glial death) was
determined for each experiment by assaying sister
cultures exposed to 1 mM glutamate for 24 h. Back-
ground LDH release was determined in control cultures
not exposed to OGD and subtracted from all experimen-
tal values. The resulting value correlated linearly with the
degree of cell loss estimated by observation of cultures
under phase-contrast microscopy or under bright-field
optics following 5 min incubation with 0.4% trypan blue,
which stains debris and nonviable cells.
3. Results
3.1. Studies in BHK cells stably transfected with
mGlu1a and mGlu5a receptors
Poly(ADP-ribosyl)ation evoked by receptor stimula-
tion was evaluated in BHK cells stably transfected with
mGlu1a and mGlu5a receptors by measuring the
formation of PAR, the product of PARP activity, with
a flow-cytometric assay (Fig. 1). In control cells, only
a background peak at low levels of relative PAR
fluorescence intensity was observed. Thirty min after the
exposure, DHPG (50e100 mM) promoted the appear-
ance of a second peak at higher levels of relative PAR
fluorescence intensity, indicative of increased PARP
activity and increased formation of PAR. The effect of
DHPG was approximately 80% of that observed with
300 mM H2O2 (15 min) and was almost completely
abolished by co-application of the selective mGlu1
receptor antagonist 3-MATIDA (100 mM, Fig. 2A). The
selective mGlu5 receptor antagonist MPEP (1 mM, used
as a negative control) had no effect. In wild-type non-
transfected BHK cells and in BHK cells transfected with
mGlu5a receptors, the formation of PARcould be elicited
only by exposure to H2O2, but not by DHPG (Fig. 2B).
PARP activity in BHK transfected cells was also
measured by immunodot blot analysis. Similarly to what
observed with flow cytometry, both the positive control
H2O2 and, to a somewhat lesser degree, DHPG
(100 mM, 30 min) significantly increased the formation
of PAR. The DHPG-evoked increase was dramatically
reduced by the mGlu1 antagonist 3-MATIDA (Fig. 3).
3.2. Studies in murine cortical cell cultures
Poly(ADP-ribosyl)ation evoked by stimulation of
mGlu receptors was evaluated in mixed cortical cells
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(Fig. 5). H2O2 (500 mM for 15 min) induced a dramatic
increase in PAR immunoreactivity in neuronal cells, but
not in the underlying glial cell layer (Fig. 4B). A much
weaker, but clearly evident, appearance of PAR-positive
staining was observed in neuronal cells following
application of the group I mGlu receptor agonist DHPG
(100 mM for 60 min, Fig. 4C), that was completely
prevented by the addition of 100 mM 3-MATIDA
(Fig. 4D). This result was confirmed by flow cytometry,
in which the exposure of neuronal cells to 100 mM
DHPG for 60 min elicited the formation of a peak at
higher levels of relative PAR fluorescence intensity,
indicating the neosynthesis of PAR (Fig. 5A). The
mGlu1 receptor selective antagonist 3-MATIDA
(100 mM) completely abolished this effect, whereas the
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Fig. 1. PARP activation following DHPG exposure in BHK cells
transfected with mGlu1a receptors. Transfected BHK cells were
exposed to 50 or 100 mM DHPG and after 30 min they were fixed,
labeled with a polyclonal antibody directed against PAR, the product
of PARP, and processed for flow cytometry analysis. (A) The graph
plots the relative number of cells displaying increasing levels of PAR
fluorescence and is representative of five analyses. DHPG exposure
elicited the formation of a peak at high levels of relative fluorescence
intensity, indicative of the neosynthesis of PAR. (B) Percentage of
PAR-positive cells in the entire cell population, as calculated by
counting the relative number of cells detected at channels for high
levels of PAR fluorescence (O350). DHPG dose-dependently increased
the formation of PAR. Results are the meanG SEM of five experi-
ments. *P! 0.05 vs. untreated control (ANOVAC Tukey’s w-test).mGlu5 receptor selective antagonist MPEP (1 mM)
reduced the DHPG-evoked increased formation of
PAR by approximately 60% (Fig. 5B).
3.3. Studies in a cortical cell model of sublethal
oxygen-glucose deprivation
In order to evaluate the functional significance of the
mGlu-PARP pathway in post-ischemic neuronal death,
we utilized murine cortical cell cultures exposed to
sublethal OGD. We selected this particular OGD model
in order to isolate the potentially toxic effects of DHPG
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Fig. 2. PARP activation in wild-type and transfected BHK cells: effects
of group I mGlu receptor antagonists. Wild-type (wt) BHK cells and
BHK cells transfected with mGlu1a or mGlu5a receptors were exposed
to 300 mM H2O2 for 15 min or 100 mM DHPG for 30 min and then
fixed, labeled with an antibody directed against PAR, the product of
PARP, and processed for flow cytometry analysis. (A) In BHK cells
transfected with mGlu1a receptors, 3-MATIDA (100 mM) or MPEP
(1 mM) were added to the incubation medium 15 min prior to DHPG.
Data are expressed as percentage of PAR-positive cells in the entire cell
population. The DHPG-induced formation of PAR was blocked by
3-MATIDA but not by MPEP. Results are the meanG SEM of at
least four experiments. **P! 0.01 vs. untreated cells (ANOVAC Tu-
key’s w-test). (B) In wild-type or mGlu5a-transfected BHK cells, H2O2
but not DHPG increased the formation of PAR. Results are the
meanG SEM of at least three experiments. **P! 0.01 vs. untreated
cells (ANOVAC Tukey’s w-test).
84 E. Meli et al. / Neuropharmacology 49 (2005) 80e88and the component of OGD injury evoked by DHPG.
As previously described (Pellegrini-Giampietro et al.,
1999a), the extent of neuronal death in this system
increased with the duration of exposure to OGD
(Fig. 6A). Hence, exposures !30 min produced little
neuronal injury when observed 24 h later, whereas
exposure durations O40 min induced increasing levels
of neuronal damage. As a sublethal OGD we selected an
exposure duration of 40 min, which caused a release of
LDH in the medium that was approximately 40% of
that observed by exposing the cultures to 1 mM
glutamate for 24 h. The addition of 100 mM DHPG to
the medium during OGD and the subsequent 24 h
recovery period significantly exacerbated neuronal
damage (Fig. 6B). The PARP inhibitor DPQ (at
10 mM) reduced the release of LDH induced by
sublethal OGD in a modest, non-significant, fashion
but completely blocked the effect of DHPG (Fig. 6B).
4. Discussion
Our results show that stimulation of group I mGlu
receptors elicits a significant increase in PARP activity
in both BHK cells transfected with mGlu1 receptors and
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Fig. 3. Immunodot blot analysis of PAR formation in BHK cells
transfected with mGlu1a receptors. Cells were treated as indicated in
Fig. 2, then proteins were extracted, loaded onto Hybond NC
membranes and incubated overnight with a monoclonal PAR
antibody. Membranes were analyzed by chemiluminescence and
quantitated with the aid of a computer-assisted software. (A) Sample
optic density increased in the positive control (H2O2) and in DHPG-
treated cells. (B) Quantitative analysis of optic densities showing that
3-MATIDA reduced the increase in PAR formation induced by
DHPG. Each bar represents the meanG SEM of four experiments.
**P! 0.01 and *P! 0.05 vs. basal (ANOVAC Tukey’s w-test).in murine cortical cell cultures. This was demonstrated
by means of flow cytometry, immunodot blot analysis
(in BHK cells) and immunocytochemistry (in neurons)
using antibodies directed against PAR, the product
of PARP activity. In addition, we show that mGlu
receptor-stimulated PARP activation may play a role in
an in vitro model of sublethal ischemia.
It has been clearly and repeatedly demonstrated that
glutamate receptors of the NMDA but not of the
AMPA type are able to activate PARP in neurons
(Mandir et al., 2000; Meli et al., 2004), possibly via the
formation of nitric oxide and peroxynitrite. The present
study shows that also group I mGlu receptors may
stimulate the formation of PAR. Our experiments
performed in BHK cells transfected with group I mGlu
receptors clearly demonstrate that activation of PARP
can be triggered by stimulation of mGlu1 but not
mGlu5 receptors. In cortical cell cultures, however,
whereas the mGlu1 receptor antagonist 3-MATIDA
completely abolished the DHPG-induced activation of
PARP, the mGlu5 receptor antagonist MPEP was also
able to reduce PARP activation, albeit to a consider-
ably lesser degree. This finding suggests that, at least in
cultured cortical neurons, PARP may be activated
preferentially by mGlu1 receptors with a partial contri-
bution of mGlu5 receptors. It is also possible that
mGlu5 receptors may be activated indirectly by gluta-
mate release following DHPG-induced depolarization.
It is not surprising that mGlu1 and mGlu5 receptors
co-expressed in the same neuronal population may serve
different physiological roles (Valenti et al., 2002). For
example, in cultured cortical neurons stimulation of
mGlu1 but not mGlu5 receptors induces potentiation
of NMDA responses via a Ca2C-calmodulin-dependent
and protein kinase C-independent Pyk2/Src-family
kinase pathway (Heidinger et al., 2002), while blockade
of mGlu1 but not mGlu5 receptors is neuroprotective
against OGD neuronal injury (Meli et al., 2002). The
diversity of mGlu1 and mGlu5 receptor functions in
these and other neurons can be explained by the tight
and independent regulation of their specific coupling to
downstream effectors or scaffolds, such as protein kinase
C, G-protein-coupled receptor kinases (GRKs), regu-
lators of G-protein signaling (RGS) proteins, and
Homer and related proteins (Valenti et al., 2002).
Our finding that the preferential activation of mGlu1
receptors leads to PARP activation is particularly
significant to the pathogenesis of cerebral ischemia. It
has been demonstrated that mGlu1 rather than mGlu5
receptors play a distinct role in the pathways leading to
post-ischemic neuronal death (Pellegrini-Giampietro,
2003). It has been proposed that the release of GABA
and the subsequent activation of GABA receptors may
contribute to the attenuation of post-ischemic injury
induced by mGlu1 receptor antagonists (Battaglia
et al., 2001; Cozzi et al., 2002), presumably via an
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legrini-Giampietro et al., 2004). Our present experi-
ments in a sublethal OGD model suggest that
stimulation of mGlu1 receptor may lead to exacerbation
of post-ischemic damage by an additional mechanism,
i.e. the activation of PARP. A large body of evidence
demonstrates that the increased neoformation of PAR
plays a crucial role in neurodegeneration. In models of
cerebral ischemia and excitotoxicity, it appears that
intracellular depletion of ATP induced by PARP-1 leads
to energy failure and necrotic neuronal death (Ha and
Snyder, 1999; Meli et al., 2004; Moroni et al., 2001). In
contrast, during the caspase-dependent apoptotic pro-
cess, PARP-1 is proteolytically cleaved and inactivated
by caspase-3, a process that is widely used as an
apoptotic marker (Oliver et al., 1998). More recent
studies have shown that PARP-1 may also have a role in
caspase-independent apoptosis, by promoting the re-
lease of apoptosis-inducing factor (AIF) from mito-
chondria (Yu et al., 2002). Because, as all other available
agents, the PARP inhibitor DPQ is not selective among
members of the family (Southan and Szabo, 2003), it is
not possible at present to identify the PARP subtype
that is activated by mGlu1 receptor stimulation.
In our model of sublethal OGD, the PARP inhibitor
DPQ was not able to reduce in a significant manner the
release of LDH induced by the pseudo-ischemic insult.
This finding may appear to be in contrast with previous
results from our laboratory showing that PARP
inhibitors are neuroprotective in cortical cell cultures
exposed to OGD (Moroni et al., 2001). It should be
noted, however, that OGD exposure in the present study
was much milder (40 vs. 60 min) and that PARP
inhibitors are known to be efficacious only when
excitotoxic or ischemic insults are particularly intense
and presumably necrotic (Bonfoco et al., 1995; Meli
et al., 2004). In cultured cortical cells, DHPG by itself is
not toxic but exacerbates LDH release and neuronal
damage following exposure to OGD (Pellegrini-Giam-
pietro et al., 1999a). Our results show that DPQ was
able to completely abolish the component of OGD
injury evoked by DHPG, strongly suggesting that PARP
overactivation is responsible for the neuronal damage
evoked by DHPG in this model.
Group I mGlu receptors are classically coupled to
PLC-b, and therefore to the formation of IP3 and
diacylglycerol which results, respectively, in intracellular
Fig. 4. PAR immunocytochemistry in murine cortical cell cultures.
Control cells (A) or cells treated with 500 mM H2O2 for 15 min (B),
100 mM DHPG for 60 min (C) or 100 mM DHPGC 100 mM
3-MATIDA for 60 min were incubated with a monoclonal anti-PAR
antibody, exposed to a fluorescent secondary antibody and observed
under fluorescence optics. H2O2 induced a dramatic increase in PAR
immunoreactivity; a weaker but significant PAR signal was observed
with DHPG that was prevented by the addition of 3-MATIDA. Scale
bar: 50 mm.
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mGlu1 and mGlu5 receptors are also linked to a variety
of other effectors, such as adenylyl cyclase, tyrosine
kinase, mitogen-activate protein kinase and phosphoi-
nositide 3-kinase, that account for their diverse physi-
ological and pathological effects (Bordi and Ugolini,
1999; Nicoletti et al., 1999; Valenti et al., 2002). Hence,
it is not surprising that these receptors can couple to
a pathway that leads to the activation of the nuclear
enzyme PARP. It has been recently shown that high-
[KC]-induced membrane depolarization in cortical
neurons promotes poly(ADP-rybosyl)ation in the
absence of DNA breaks or NAD depletion (Homburg
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Fig. 5. PARP activation following DHPG exposure in murine cortical
neurons. Cultures were exposed to 100 mM DHPG and after 60 min
they were fixed, labeled with antibodies directed against PAR and
GFAP, and processed for flow cytometry analysis. The GFAP-positive
contribution to PAR fluorescence was subtracted from all samples. (A)
The graph plots the relative number of cells displaying increasing levels
of PAR fluorescence and is representative of five analyses. DHPG
exposure elicited the formation of a peak at high levels of relative
fluorescence intensity, indicative of the neosynthesis of PAR, that was
reduced by 3-MATIDA (100 mM). (B) Percentage of PAR-positive
cells in the entire neuronal population, as calculated by counting the
relative number of neurons detected at channels for high levels of PAR
fluorescence (O350). The DHPG-induced increase in PAR formation
was completely reduced by 3-MATIDA (100 mM) and partly reduced
by MPEP (1 mM). Results are the meanG SEM of five experiments.
**P! 0.01 and *P! 0.05 vs. untreated controls (ANOVAC
Tukey’s w-test).et al., 2000), a process that appears to be mediated by
IP3-induced intracellular Ca
2C release. Indeed, IP3
production in depolarized neurons can be stimulated
not only by phosphoinositide breakdown, but also by
stimulation of tyrosine kinases or activation of trimeric
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Fig. 6. The PARP inhibitor DPQ attenuates DHPG-induced neuronal
damage in a model of sublethal OGD. (A) Time-dependent increase of
neuronal death following different periods of OGD. Cells were exposed
to OGD for the indicated period and neuronal death was assessed 24 h
later by measuring LDH release in the medium. Data are expressed as
percent of maximal damage, as produced by a 24-h exposure to 1 mM
glutamate. For sublethal OGD experiments, a 40-min period was
chosen (arrow). (B) Cultures were exposed to 40 min OGD and
neuronal death was measured 24 h later. Data are expressed as percent
of sublethal OGD-induced neuronal death. Application of 100 mM
DHPG resulted in significant exacerbation of neuronal damage that
was attenuated by co-administration of the PARP-1 inhibitor DPQ
(10 mM). Values represent the meanG SEM of at least five experi-
ments. **P! 0.01 vs. sublethal OGD and ##P! 0.01 vs. DHPG
(ANOVAC Tukey’s w-test).
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receptors and IP3-gated Ca
2C stores have been identified
in the nuclear membrane (Gerasimenko et al., 1995).
Group I mGlu receptors, and mGlu1 receptors in
particular, may therefore trigger the nuclear formation
of PAR via the production of IP3, that then may act at
the nuclear level to promote the activation of PARP and
the formation of PAR.
In conclusion, PARP activation via mGlu1 receptor
stimulation constitutes a novel pathway that may be of
relevance in a number of physiological and pathological
processes in neurons. For example, in view of the
involvement of mGlu1 receptors in long-term potenti-
ation and depression and the role of PARP in the
regulation of gene expression and transcription, this
mechanism may be operative in processes that are
required for memory storage and consolidation (Cohen-
Armon et al., 2004). In addition, our data suggest that
the interplay between mGlu1 receptors and PARP may
be responsible for the neuroprotective effects observed
with mGlu1 receptor antagonists and PARP inhibitors
in experimental models of cerebral ischemia.
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